Showing results (161-170 of 435) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|August 5, 2025
Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP)Rebecca Rizzo, Paolo Rainone, Rachele Stefania, et al.
EJNMMI Radiopharmacy and Chemistry|August 5, 2025
Production of 211At and automated radiosynthesis of [211At]MABG via electrophilic astatodesilylationYuto Kondo, Taiki Joho, Shigenori Sasaki, et al.
EJNMMI Radiopharmacy and Chemistry|September 26, 2025
Design and characterization of a novel prostate-specific membrane antigen-targeted radioligand modified with a fatty acid albumin binder for optimized circulation half-lifeShaomei Zeng, Xiang Gao, Jiang Meng, et al.
EJNMMI Radiopharmacy and Chemistry|September 26, 2025
Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modificationsKatarína Hajduová, Kateřina Dvořáková Bendová, Miloš Petřík, et al.
EJNMMI Radiopharmacy and Chemistry|August 21, 2021
Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic reviewNanno Schreuder, Iris de Romijn, Pieter L Jager, et al.
EJNMMI Radiopharmacy and Chemistry|July 14, 2025
Development of a halofluorocarbon, chromatography-free radiosynthesis of fluorine-18 difluorocarbeneCatherine G F Dickmann, Andrew D Bond, Selena Milicevic Sephton, et al.
EJNMMI Radiopharmacy and Chemistry|July 6, 2025
Development of a CYP11B2 imaging tracer for primary aldosteronism: basic evaluation of iodine- and fluorine-incorporated pyridinyldihydroquinolinone derivativesYusuke Yagi, Hiroyuki Kimura, Riko Fuseda, et al.
EJNMMI Radiopharmacy and Chemistry|July 22, 2025
Development and evaluation of a 99mTc-labeled olaparib analog for PARP imagingWei Xu, Junjie Yan, Xinlin Zhong, et al.
EJNMMI Radiopharmacy and Chemistry|June 21, 2025
Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progressAbdelrahman Homedan, Darpan N Pandya, Nicholas J Schnicker, et al.
EJNMMI Radiopharmacy and Chemistry|July 17, 2025
Auger electron-emitting EGFR-targeted and non-targeted [197Hg]Hg-gold nanoparticles for treatment of glioblastoma multiforme (GBM)Madeline K Brown, Zhongli Cai, Constantine J Georgiou, et al.
Pageof 44